Las Vegas Sands......beobachten

nur noch kurz.... schau dir das an, wie da gespielt wird.  Ohne Worte!!!


Pre-Market

08:48  $ .42 100
08:00  $ .3252 1,000
08:00  $ .32 1,000  

Klasse statt Masse.  

Goldman Sachs Boosts Estimates and Price Target On Las Vegas Sands (LVS), Maintains Neutral

August 2, 2010 10:08 AM EDT

Goldman Sachs raised estimates and its price target on Las Vegas Sands Corp. (NYSE: LVS) from $23 to $26, but kept its Neutral rating on the stock.

2010 EPS goes from $0.41 to $0.64, 2011 from $0.65 to $1.02 and 2012 from $0.90 to $1.12. The estimates move materially higher as the firm now assumes no share count dilution from warrant conversion.

The firm maintained EBITDA forecasts for Las Vegas, but raises EBITDA forecasts for Macau.

The Neutral rating is maintained as they firm views the strong growth evident in Macau and Singapore as already priced into the stock. The firm also sees uncertainty around the sale of the company's Four Seasons apartments in Macau.

http://www.streetinsider.com/Analyst+Comments/...Neutral/5853618.html  

http://www.mysmartrend.com/news-briefs/news-watch/...dustry-lvs-dde-m  

Macau’s casino gross gaming revenue reached MOP16.3 billion (US$2 billion) last month, the second highest value ever.
It represents a yearly increase of 70.4 percent, according to data released by the Gaming Inspection and Coordination Bureau (DICJ).
The total casino gross gaming revenue for the seven months through to July rose 67.5 percent year-on-year to MOP102.2 billion.
That is almost as much as the local casinos ranked in on the overall 2008 (MOP108.8 billion).

http://www.macaubusiness.com/news/gaming-revenue-up-70-percent/4278/  

http://data.cnbc.com/quotes/LVS  

WORCESTER, Mass., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT - News) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has created a scientific advisory board in an effort to further its drug development programs, specifically in the areas of oncology and metabolic diseases. Management of Generex has been in late stage talks with a number of key industry leaders in the pharmaceutical and biotechnology industry to assist the Company in positioning its more later stage drug delivery and vaccine programs for commercialization and to further the advancement of its rich pipeline of metabolic and oncology related programs.



"We believe we are at the cusp of several significant advancements toward the commercial realization for the sciences we have been developing at our Company since our inception. We are confident that now is the time to bring a number of industry leaders together to help to guide our Company down the path to commercial success," stated Anna Gluskin, the Company's President & Chief Executive Officer. "We have been in discussions with some current industry leaders in oncology and metabolic diseases and we look forward to bringing in a group of professionals capable of providing us with the additional experience and insight to help us deliver on the promise of our strong pipeline of life improving drug programs."

wird langsam Zeit, dass das Ganze endlich mal Früchte trägt aber ist halt eine Biobude.

Gruß
Dude44  

http://finance.yahoo.com/news/...ates-pz-3199254391.html?x=0&.v=1

Gruß
Dude44  

 

 

Ob der Kurs nach Norden heute weitergeht ?  

Pre-Market        Pre-Market        Price Pre-Market        
Time (ET)           Price                 Share Volume  
4:00                  $ 27.22             3,900

http://www.nasdaq.com/aspxcontent/...spx?selected=LVS&mkttype=pre  

Du auf 4.000 St.  - Es soll wohl heißen 3.900 Tsd  

Ich weiß.
Einmal wurden 3.900 Stück zu $27.22 und einmal
100 Stück zu $27.89 gehandelt.

Ich frage mich nur, warum jemand 3.900 Stück
zu $27.22 verkauft bzw. zum Verkauf gestellt hat.
Irgendwelche Schlitzohren sollen m.E. wieder den Markt
manipulieren.  

dass nach dem tollen Anstieg seit Ende Juni wieder
die Zocker aus den Löchern kommen.  

Habe da mal ne Frage?

Habe letzten s 1400 Euro bei der LVS liegen lassen,weil ich nicht verkauft habe.
Bin  dann ins minus gerutscht und  jetzt wieder raus .

Wo sieht  ihr denn besten Punkt zu verkaufen ?

22-23 Euro sagt mir mein Bauchgefühl wären ein guter Punkt zu Verkaufen.

Was sagt Ihr.  

Heute Abend werden wir es wissen.
Ich glaube, daß mit so einer Order wieder etwas Panik
in den Markt gebracht werden soll. Einige werden sich sicherlich
heute an den $27.22 orientieren und vielleicht ihre shares
zu diesem Preis abgeben. Ich persönlich glaube, daß die Aktie
bis an $32 hochlaufen und es dann zu einem Rücksetzer kommen
wird. Viel hängst sicherlich auch von den Quartalszahlen von
MGM Resorts ab, die heute veröffentlicht werden.

MGM Resorts

The casino resorts are expected to announce a loss of 24 cents a share on revenue of $1.46 billion.

2nd Qtr.         Estimate        Year Ago
EPS                $-0.24            $-0.12
Revenue        $1.46 B           $1.49 B

http://www.cnbc.com/id/38524869  

Es kommt drauf an was du möchtest?! Kurzfristiges oder Langfristig. Da mich kurzfristig nicht interessiert, mache ich mir auch keinen Gedanken drüber bzw. zocke ich bei LVS nicht.

Langfristig warte bis 50$ und dann kannst du mich noch mal fragen. :-))  

gesehen haben wir nicht mehr viel Luft nach oben, aber vll. bricht es ja mal nach oben aus.  

Pre-Market bei LVS sieht genauso aus wie gestern bei GNBT. :-((  

Macau July Gross Gambling Revenue Rises 70% To MOP16.3 Billion

HONG KONG -(Dow Jones)- Macau's July gross gambling revenue jumped 70% from a year earlier and rose 20% from June, picking up after the end of the soccer World Cup, which analysts said had suppressed high-stakes gambling last month.

July revenue totaled MOP16.3 billion (US$2.0 billion) compared with the MOP13.6 billion recorded in June, according to data from Macau's Gaming Inspection and Coordination Bureau. It didn't provide the July 2009 figure for comparison.

July's figure is the second-highest so far this year after May's record MOP17.1 billion.

But July may be the last month for easy year over year comparisons, wrote Citigroup analyst Anil Daswani in a recent report, noting monthly gambling revenue hasn't fallen below MOP10 billion since July 2009.

CLSA analysts Huei Suen Ng and Aaron Fischer said they expect gambling revenue in the Chinese territory to rise 34% from a year earlier in the second half of this year following the first half's 67% growth.

Among Macau's six casino license-holders, tycoon Stanley Ho's SJM Holdings Ltd. (0880.HK) continued to lead the market with a share of 32%; followed by Las Vegas Sands Corp. unit Sands China Ltd. (1928.HK) with 19%; and Wynn Resorts Ltd. unit Wynn Macau Ltd. (1128.HK) with 15%, according to CLSA. Compared to the brokerage's June market share figures, SJM gained two percentage points while Wynn and Sands lost two each.

Melco Crown Entertainment Ltd. (MPEL), co-chaired by James Packer and Lawrence Ho, had a market share of 15%; Galaxy Entertainment Group Ltd. (0027.HK) 12%; and MGM Macau, a joint venture between Pansy Ho and MGM Resorts International ( MGM), had 7%, CLSA said.

Solid July revenue figures are significant for two reasons, Nomura analyst Charlene Liu said in a report Friday: first, the performance should help dismiss some of the market's concerns that property cooling measures announced by China in mid-April could have a negative impact on Macau gambling revenue with a three-month delay. Second, a strong July despite typical seasonal weakness will set a positive tone for the next six months, she said.

http://www.nasdaq.com/aspx/...bling-revenue-rises-70to-mop163-billion  

Und was heißt das ?
Aktuell $33.10 wären mir lieber.  

Zum Glück liegen die Quartalszahlen
von Las Vegas Sands (LVS) bereits vor !!!!!!!

MGM Resorts International Reports Second Quarter Results
Year over Year Las Vegas Strip REVPAR Comparisons Improve Sequentially for the Fifth Consecutive Quarter;
Convention Booking Trends Continue to Improve

LAS VEGAS, Aug. 3 /PRNewswire-FirstCall/ -- MGM Resorts International (NYSE:MGM - News) today announced its financial results for the second quarter of 2010. The Company recorded a second quarter diluted loss per share of $2.00 compared to a loss of $0.60 per share in the prior year second quarter. The current year results include a pre-tax non-cash charge of approximately $1.12 billion (or $1.64 per share, net of tax) relating to an impairment of the Company’s investment in the CityCenter joint venture and a pre-tax non-cash charge of approximately $29 million (or $0.04 per share, net of tax) representing the Company’s share of an impairment of CityCenter’s residential inventory.  The prior year results include non-cash impairment charges of $188 million (or $0.34 per share, net of tax), primarily related to the Company’s investment in a convertible note, and losses on the retirement of long-term debt of $58 million (an impact of $0.11 per share, net of tax).

The following table lists items which affect the comparability of the current and prior year quarterly results (approximate per diluted share impact shown, net of tax; negative amounts represent charges to income):

http://finance.yahoo.com/news/...-prnews-4046617359.html?x=0&.v=1